Primary prophylaxis for cryptococcal meningitis and impact on mortality in HIV: a systematic review and meta-analysis

The impact of routine cryptococcal antigen screening on survival among HIV-infected individuals with advanced immunosuppression in Kenya

(2013) A.-C. L. Meyer et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial

(2011) Rosalind Parkes-Ratanshi et al.   LANCET INFECTIOUS DISEASES

Missed Opportunities for HIV Testing and Late-Stage Diagnosis among HIV-Infected Patients in Uganda

(2011) Rhoda K. Wanyenze et al.   PLoS One

Cost‐Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV‐Infected Persons with a CD4+Cell Count ⩽100 Cells/μL Who Start HIV Therapy in Resource‐Limited Settings

(2010) David B. Meya et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Cost-Effectiveness of Primary Prophylaxis of AIDS Associated Cryptococcosis in Cambodia

(2010) Romain Micol et al.   PLoS One

Outcomes of Cryptococcal Meningitis in Uganda Before and After the Availability of Highly Active Antiretroviral Therapy

(2008) Andrew Kambugu et al.   CLINICAL INFECTIOUS DISEASES